Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1995-04-25
2000-02-01
Housel, James C.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 71, 435192, 514556, G01N 3353, C12N 908, A01N 3730
Patent
active
060201398
ABSTRACT:
A new paradigm of disease centers around the metabolic pathways of S-adenosyl-L-methionine (SAM), the intermediates of these pathways and other metabolic pathways influenced by the SAM pathways. Methods are provided to analyze and modulate SAM pathways associated with a disease or condition. Such methods permit identification and utilization of diagnostic and therapeutic protocols and agents for such disease states and conditions.
REFERENCES:
patent: 4373097 (1983-02-01), Stramentinoli et al.
patent: 4465672 (1984-08-01), Gennari
patent: 4499072 (1985-02-01), Sunkara et al.
patent: 4971986 (1990-11-01), Stanek et al.
patent: 5043268 (1991-08-01), Stock
patent: 5132293 (1992-07-01), Shander et al.
patent: 5180714 (1993-01-01), Sufrin et al.
patent: 5389653 (1995-02-01), Bernauer et al.
patent: 5428063 (1995-06-01), Barak et al.
patent: 5476875 (1995-12-01), Bernauer et al.
Baker et al., "2'-Deoxy-2'-methylenecytidine and 2'-Deoxy-2',2'-difluorocytidine 5'-Diphosphates: Potent Mechanism-Based Inhibitors of Ribonucleotide Reductase" J. Med. Chem. 34:1879-1884 (1991).
Berger, "Cancer Chemotherapy: New Stategies for Success" J. Clin. Invest. 78:1131-1135 (1986).
Beutler, et al., "2-Chlorodeoxyadenosine: Hairy Cell Leukemia Takes a Surprising Turn" Blood Cells 19:559-568 (1993).
Blaney, et al. "Structure-Activity Relationships of Dihydrofolate Reductase Inhibitors" Chem. Rev. 84:333-407 (1984).
Borchardt, et al., "Experimental and Clinical Role of S-Adenosylmethionine" Biological Methylation and Drug Design Humana Press pp. 363-370.
Bottiglieri, et al. "The Clinical Potential of Ademetionine (S-Adenosylmethionine) in Neurological Disorders" Drugs 48 (2):137-152 (1994).
Byers, et al., "The role of hypusine depletion in cytostasis induced by S-adenosyl-L methionine decarboxylase inhibition: new evidence provided by 1-methylspermidine and 1,12-dimethylspermine" Biochem. J. 303:363-368 (1994).
Chrominski, et al., "Exposure to Ethylene Changes Nymphal Growth Rate and Female Longevity in the Grasshopper Melanoplus sanguinipes" Naturwissenschaften 69:45-46 (1982).
Cui, et al., "Suppression of Rat Hepatoma Cell Growth by Expression of Phosphatidylethanolamine N-Methyltransferase-2" The Journal of Biological Chemistry 269:24531-24533 (1994).
Dubois, et al., "Variation of choline-substituted lipid metabolism in doxorubicin-resistant leukemia cells" Biomed & Pharmacother 46:485-490 (1992).
Eliasson, et al., "Interaction of 2'-Modified Azido- and Haloanalogs of Deoxycytidine 5'-Triphosphate with the Anaerobic Ribonucleotide Reductase of Escherichia Coli" The Journal of Biological Chemistry 269:26116-26120 (1994).
Erlichman, "Novel chemotherapeutic agents in clinical development" Current Opinion in Oncology 3:1037-1042 (1991).
Friedel, "S-Adenosyl-L-Methioniney" Drugs 38(3):389-416 (1989).
Gundun, et al. "Absence of RNA-guanine transglycosylase in a human colon adenocarcinome cell line" Biochimica et Biophysica Acta 1139:229-238 (1992).
Harrison, "Ethylene, an Ovulatory Hormone?" The Lancet pp 438 (1981).
Hartman, "Molecular Aspects and Mechanism of Action of Dihydrofolate Reductase Inhibitors" Journal of Chemotherapy 5:369-376 (1993).
Hopkin, "Move Over, Mutations: DNA Methylation May Drive Cancer, Too" The Journal of NIH Research 7:26-28 (1995).
Hrycyna, et al., "Modification of Eukaryotic Signaling Proteins by C-Terminal Metehylation Reactions" Pharmac. Ther. 59:281-300 (1993).
Huang, et al., "Relationship of the Queuine Content of Transfer Ribonucleic Acids to Histopathological Grading and Survival in Human Lung Cancer" Cancer Research 52:4696-4700 (1992).
Kamatani, et al., "Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme" Proc. Natl. Acad. Sci. USA 78:1219-1223 (1981).
Kerr, "Competing Methyltransferase Systems" The Journal of Biological Chemistry 247:4248-4252 (1972).
Kido, et al., "Effects of Methylthiodeoxyadenosime and Its Analogs on in vitro Invasion of Rat Ascites Hepatoma Cells and Methylation of Their Phospholipids" Jpn. J. Cancer Res. 82:1104-1111 (1991).
Konig, "A Long-Term (Two Years) Clinical Trial With S-Adenosylmethionine for the Treatment of Osteoarthritis" The American Journal of Medicine 83:89-93 (1987).
Laird, et al., "Suppression of Intestinal Neoplasia by DNA Hypomethylation" Cell 81:197-205 (1995).
Luckhardt, et al., "Clinical Experiences With Ethylene-Oxigen Anesthesia" J. Amer. Med. Assoc. 81:1851-1857 (1923).
Marton, "Polyamines as Targets for Therapeutic Intervention" Annu.Rev. Pharmacol. Toxicol. 35:55-91 (1995).
Nishimura, et al., "Characterization and Analysis of Oncofetal tRNA and Its Possible Application for Cancer Diagnosis and Therapy" Recent Result in Cancer Research 84:401-412 (1983).
Pegg, et al., "S-Adenosylmethionine Decarboxylase as an Enzyme Target for Therapy" Pharmac. Ther. 56:359-377 (1992).
Purifoy, et al., "Review of Research Leading to New Anti-Herpesvirus Agents in Clinical Development: Valaciclovir Hydrochloride (256U, the L-Valyl Ester of Acyclovir) and 882C, a Specific Agent for Varicella Zoster Virus" Journal of Medical Virology Supplement 1:139-145.
Selhub, et al., "The Pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocystein" American Society for Clinical Nutrition 55:131-138 (1992).
Smith, et al., "Tumor-specific, Hypomodified Phenylalanyl-tRNA is Utilized in Translation in Preference to the Fully Modified Isoacceptor of Normal Cells" The Journal of Biological Chemistry 260:147-151 (1985).
Sufrin, et al., "Differential kinetic properties of L-2-amino-4-methylthio-cis-but-3-enoic acid, a methionine analog inhibitor of S-adenosylmethionine synthetase" Biochimica et Biophysica Acta, 1202:87-91 (1993).
Swift, et al., "Gram-negative bacterial communication by N-acyl homoserine lactones: a universal language?" Trends in Microbiology 2:193-198 (1994).
Wolfe,et al., "S-Adenosyl L-homocysteine Hydrolase as a Target for Antiviral Chemotherapy" Journal of Medical Chemistry 34:1521-1530 (1991).
Williams-Ashman et al., "Trends in the Biochemical Pharmacology of 5'-Deoxy-5'-Methylthioadenosine" Biochemical Pharmacology 31:277-288 (1982).
Wolos, et al., "Selective Inhibition of T Cell Activation by an Inhibitor of S-Adenosyl-L-Homocysteine Hydrolase" The Journal of Immunology 150:3264-3273 (1993).
If Love Can Last, Why Not Flowers? Houston Chronicles Feb. 12, 1992.
Reddi et al "Biotin Supplementation improves glucose & insulin tolerances in genetically diabetic k k mice." Life Sci., 42:1323-1330, 1998.
O'Day Christine L.
Schwartz Dennis E.
Vermeulen Nicolaas M. J.
Housel James C.
Oridigm Corporation
Swartz Rodney P.
LandOfFree
S-adenosyl methionine regulation of metabolic pathways and its u does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with S-adenosyl methionine regulation of metabolic pathways and its u, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and S-adenosyl methionine regulation of metabolic pathways and its u will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-936298